Showing 5571-5580 of 5771 results for "".
- Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launchhttps://modernod.com/news/kala-pharmaceuticals-strengthens-commercial-organization-in-preparation-for-first-product-launch/2480159/Kala Pharmaceuticals announced the following key commercial hires in preparation for the potential approval and launch of Inveltys, a twice-daily steroid eye drop in development for the treatment of inflammation and pain following ocular surgery: Kathleen McCann Kline, Vice President
- Free Cataract Removal Surgeries for Those in Needhttps://modernod.com/news/free-cataract-removal-surgeries-for-those-in-need/2480160/The Hawaiian Eye Foundation (HEF) performs free sight-restoring cataract surgeries for those that are uninsured and underinsured in Hawaii. With the incredible support of the Atherton Family Foundation, the 2nd Annual
- Bausch + Lomb Initiates Clinical Trial Evaluating New Ophthalmic Viscosurgical Devicehttps://modernod.com/news/bausch-lomb-initiates-clinical-trial-evaluating-new-ophthalmic-viscosurgical-device/2480163/Bausch + Lomb announced that it has initiated a clinical trial evaluating the safety and efficacy of a new ophthalmic viscosurgical device (OVD). Bausch + Lomb aims to file for premarket approval (PMA) with the FDA at the conclusion of the clinical trial, with plans to bring this next-generation
- Valeant Will Become Bausch Health Companieshttps://modernod.com/news/valeant-will-become-bausch-health-companies-inc/2480165/Valeant Pharmaceuticals International announced that the company will change its name to Bausch Health Companies beginning in July 2018. “Becoming Bausch Health Companies is a major step forward in our transformation,” Joseph C. Papa, chairman and CEO, Valeant, said in a compan
- Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globallyhttps://modernod.com/news/alcon-cares-project-100-commits-to-reducing-cataract-blindness-globally/2480168/Alcon announced Alcon Cares Project 100, which aims to reduce cataract blindness by providing equipment to perform phaco surgeries. Alcon Cares, a foundation that oversees equipment and product donations to those in need, will give 100 rep
- Bausch + Lomb Launches Lumify, the First OTC Redness Relieving Eye Drop With Low-Dose Brimonidinehttps://modernod.com/news/bausch-lomb-launches-lumify-the-first-otc-redness-relieving-eye-drop-with-low-dose-brimonidine/2480169/Bausch + Lomb announced the launch of Lumify (brimonidine tartrate ophthalmic solution 0.025%), the first and only over-the-counter (OTC) eye drop developed with low-dose brimonidine tartrate for the treatment of eye redness. “With the availability of Lumify, consumers now have an in
- Optos Unveils Monaco Ultra-Widefield Imaging Device with OCT Capabilitieshttps://modernod.com/news/optos-unveils-monaco-ultra-widefield-imaging-device-with-oct-capabilities/2480175/Optos has announced that Monaco, which the company describes as the first ultra-widefield imaging device combined with OCT, was launched Thursday in the United States. Monaco is a compact desk-top UWF retinal imaging device that provides greater imaging functionality and expands the compan
- ReGenTree Presents Results of a Comparison Study of RGN-259 and Approved Prescription Drugs for Dry Eyehttps://modernod.com/news/regentree-presents-results-of-a-comparison-study-of-rgn-259-and-approved-prescription-drugs-for-dry-eye-syndrome-in-a-mouse-model-at-arvo/2480176/ReGenTree announced that the company presented results of a comparison study of RGN-259 and marketed products for dry eye syndrome in a dry eye mouse model at the ARVO meeting. The study was conducted by Jaewook Yan
- Nicox Presents Scientific Data for NCX 667 at ARVOhttps://modernod.com/news/nicox-presents-scientific-data-for-ncx-667-at-arvo/2480179/Nicox announced a poster presentation highlighting scientific data for NCX 667, a novel nitric oxide (NO) donating compound, at the Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, one of the key scientific events in the ophthalmology calendar, being held on April
- OWL: Advancing Diversity in Leadership Appoints New Executive Director, Gaynor Frieshttps://modernod.com/news/owl-advancing-diversity-in-leadership-appoints-new-executive-director-gaynor-fries/2480180/OWL: Advancing Diversity in Leadership announced that Gaynor Fries has been appointed Executive Director of the organization. Gaynor has been a key part of the support team behind OWL since July 2015. With a BA in Business Administration and a Certificate in Non-Profit Management from Duke